chr10-133279803-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_006659.4(TUBGCP2):c.2672C>T(p.Pro891Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,572,708 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006659.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBGCP2 | NM_006659.4 | c.2672C>T | p.Pro891Leu | missense_variant | 18/18 | ENST00000252936.8 | NP_006650.1 | |
TUBGCP2 | NM_001256617.2 | c.2756C>T | p.Pro919Leu | missense_variant | 19/19 | NP_001243546.1 | ||
TUBGCP2 | NM_001256618.2 | c.2282C>T | p.Pro761Leu | missense_variant | 17/17 | NP_001243547.1 | ||
TUBGCP2 | NR_046330.2 | n.3392C>T | non_coding_transcript_exon_variant | 18/18 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000382 AC: 7AN: 183222Hom.: 0 AF XY: 0.0000401 AC XY: 4AN XY: 99748
GnomAD4 exome AF: 0.0000268 AC: 38AN: 1420492Hom.: 0 Cov.: 31 AF XY: 0.0000256 AC XY: 18AN XY: 703468
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.2672C>T (p.P891L) alteration is located in exon 18 (coding exon 17) of the TUBGCP2 gene. This alteration results from a C to T substitution at nucleotide position 2672, causing the proline (P) at amino acid position 891 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 26, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at